The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of Khorana score to predict VTE in patients undergoing chemotherapy for uterine cancer.
 
Vincent Wagner
No Relationships to Disclose
 
Monica Levine
No Relationships to Disclose
 
Rachael Piver
No Relationships to Disclose
 
Floor Jenniskens Backes
Consulting or Advisory Role - Abbott Diagnostics (I); Agenus; AstraZeneca; Clovis Oncology; CMR Institute; Eisai; Genentech; GlaxoSmithKline; Merck
Research Funding - Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate (for writing a chapter)
 
David E. Cohn
Consulting or Advisory Role - Oncology Analytics
Research Funding - AbbVie (Inst); Advaxis (Inst); Agenus (Inst); Ajinomoto (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Ergomed (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Gynecologic Oncology Group (Inst); Henry Jackson Foundation (Inst); ImmunoGen (Inst); INC Research (Inst); inVentiv Health (Inst); Janssen Research & Development (Inst); Ludwig Institute for Cancer Research (Inst); Novartis (Inst); NRG Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); PRA International (Inst); Regeneron (Inst); Sanofi (Inst); Stemcentrix (Inst); Tesaro (Inst); Tricon Pharmaceuticals (Inst)
Other Relationship - Elsevier; UpToDate
 
Larry J. Copeland
Consulting or Advisory Role - Agenus; AstraZeneca; Asymmetric Therapeutics; Boston Biomedical; Iovance Biotherapeutics; Myriad Genetics; Novocure; Tarveda Therapeutics; Tarveda Therapeutics; Tesaro
 
Casey Cosgrove
No Relationships to Disclose
 
Jeffery Fowler
No Relationships to Disclose
 
David M. O'Malley
Consulting or Advisory Role - Abbvie; Agenus; Ambry Genetics; AstraZeneca; Clovis Oncology; Eisai; Elevar Therapeutics; Genelux; Genentech/Roche; GlaxoSmithKline; GOG Foundation; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Leap Therapeutics; Marker Therapeutics; Myriad Genetics; Novartis; Novocure; OncoQuest; Regeneron; Rubius Therapeutics; Rubius Therapeutics; Seagen; Sorrento Therapeutics; Tarveda Therapeutics; Tesaro; Translational Genomics Research Institute
Research Funding - Abbvie (Inst); Abbvie/Stemcentrx (Inst); Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); Eisai (Inst); Eisai (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Genmab (Inst); Immunogen (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Janssen Research & Development (Inst); Leap Therapeutics (Inst); Merck (Inst); Mersana (Inst); PharmaMar (Inst); Regeneron (Inst); Seagen (Inst); Tesaro (Inst); TRACON Pharma (Inst)
 
Kristin Leigh Bixel
Consulting or Advisory Role - Intuitive Surgical
Research Funding - Intuitive Surgical